Cefepime population pharmacokinetics and dosing regimen optimization in critically ill children with different renal function
- 20 May 2022
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 28 (10) , 1389.e1-1389.e7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsisIntensive Care Medicine, 2016
- A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2015
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?Clinical Infectious Diseases, 2014
- Pediatric acute kidney injury assessed by pRIFLE as a prognostic factor in the intensive care unitPediatric Nephrology, 2012
- Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactamsCritical Care, 2011
- Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shockCritical Care, 2010
- Human renal function maturation: a quantitative description using weight and postmenstrual agePediatric Nephrology, 2009
- Population pharmacokinetics of cefepime in neonates with severe nosocomial infectionsJournal of Clinical Pharmacy and Therapeutics, 2008
- Population Pharmacokinetics of Cefepime in the NeonateAntimicrobial Agents and Chemotherapy, 2005
- Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1985